Cogent Biosciences Inc (COGT)

Finanzdaten der Cogent Biosciences Inc-Aktie (COGT)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
	6.04%70.81	75.37	75.56	68.99	62.20
Research and Development	6.04%70.81	75.37	75.56	68.99	62.20
Costs And Expenses	0.94%102.64	103.61	99.49	83.36	75.58
Depreciation and Amortization	18.37%0.74	0.63	0.66	0.64	0.66
Operating Income/Loss	0.94%-102.64	-103.61	-99.49	-83.36	-75.58
Nonoperating Income/Loss	0.35%6.23	6.26	-3.00	2.43	2.05
	0.97%-96.41	-97.35	-102.49	-80.93	-73.53
Attributable To Parent	0.97%-96.41	-97.35	-102.49	-80.93	-73.53
Basic Average Shares	5.43%171.01	162.19	7.04	137.55	114.47
Diluted Average Shares	5.43%171.01	162.19	7.04	137.55	114.47
Basic Earnings Per Share	1.89%-0.52	-0.53	-0.61	-0.50	-0.53
Diluted Earnings Per Share	1.89%-0.52	-0.53	-0.61	-0.50	-0.53